Nanobiotix S.A. (NBTX)
NASDAQ: NBTX · Real-Time Price · USD
22.78
+2.27 (11.07%)
At close: Oct 6, 2025, 4:00 PM EDT
21.95
-0.83 (-3.64%)
Pre-market: Oct 7, 2025, 4:38 AM EDT

Nanobiotix Statistics

Total Valuation

Nanobiotix has a market cap or net worth of $1.05 billion. The enterprise value is $1.07 billion.

Market Cap1.05B
Enterprise Value 1.07B

Important Dates

The last earnings date was Tuesday, September 30, 2025, after market close.

Earnings Date Sep 30, 2025
Ex-Dividend Date n/a

Share Statistics

Nanobiotix has 48.21 million shares outstanding. The number of shares has increased by 10.33% in one year.

Current Share Class n/a
Shares Outstanding 48.21M
Shares Change (YoY) +10.33%
Shares Change (QoQ) +0.03%
Owned by Insiders (%) 3.30%
Owned by Institutions (%) 5.99%
Float 30.85M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 87.65
Forward PS 26.14
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 89.85
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.63

Current Ratio 0.63
Quick Ratio 0.58
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -5.19

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -41.64%
Return on Invested Capital (ROIC) -567.28%
Return on Capital Employed (ROCE) 245.90%
Revenue Per Employee $110,470
Profits Per Employee -$561,569
Employee Count108
Asset Turnover 0.15
Inventory Turnover n/a

Taxes

Income Tax -43,453
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +338.92% in the last 52 weeks. The beta is 1.58, so Nanobiotix's price volatility has been higher than the market average.

Beta (5Y) 1.58
52-Week Price Change +338.92%
50-Day Moving Average 10.55
200-Day Moving Average 5.50
Relative Strength Index (RSI) 84.16
Average Volume (20 Days) 113,541

Short Selling Information

Short Interest 11,042
Short Previous Month 23,504
Short % of Shares Out 0.02%
Short % of Float 0.04%
Short Ratio (days to cover) 0.76

Income Statement

In the last 12 months, Nanobiotix had revenue of $11.93 million and -$60.65 million in losses. Loss per share was -$1.28.

Revenue11.93M
Gross Profit 11.93M
Operating Income -51.59M
Pretax Income -60.69M
Net Income -60.65M
EBITDA -51.49M
EBIT -51.59M
Loss Per Share -$1.28
Full Income Statement

Balance Sheet

The company has $33.84 million in cash and $60.18 million in debt, giving a net cash position of -$26.33 million or -$0.55 per share.

Cash & Cash Equivalents 33.84M
Total Debt 60.18M
Net Cash -26.33M
Net Cash Per Share -$0.55
Equity (Book Value) -80.98M
Book Value Per Share -1.68
Working Capital -27.18M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$36.55 million and capital expenditures -$595,420, giving a free cash flow of -$37.04 million.

Operating Cash Flow -36.55M
Capital Expenditures -595,420
Free Cash Flow -37.04M
FCF Per Share -$0.77
Full Cash Flow Statement

Margins

Gross Margin 100.00%
Operating Margin -432.39%
Pretax Margin -508.71%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Nanobiotix does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -10.33%
Shareholder Yield -10.33%
Earnings Yield -5.80%
FCF Yield -3.54%

Analyst Forecast

The average price target for Nanobiotix is $8.00, which is -64.88% lower than the current price. The consensus rating is "Strong Buy".

Price Target $8.00
Price Target Difference -64.88%
Analyst Consensus Strong Buy
Analyst Count 1
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Nanobiotix has an Altman Z-Score of -2.82 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -2.82
Piotroski F-Score 1